βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|2|598-612

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.2, 2015-02, pp. : 598-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wnt Signaling Pathway in Invasive Ductal Carcinoma of the Breast: Relationship between β-Catenin, Disheveled and Cyclin D1 Expression

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 112-117

Karger

Access to resources Recommend Favorite

CUL4B activates Wnt/β‐catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 5, 2015-04 ,pp. : 784-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

CGK‐211, a Novel Carbazole Derivative, Suppresses Canonical Wnt Signaling by Promoting β‐Catenin Degradation

By  

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 36, Iss. 4, 2015-04 ,pp. : 1262-1265

John Wiley & Sons Inc

Access to resources Recommend Favorite

PCDH20 functions as a tumour‐suppressor gene through antagonizing the Wnt/β‐catenin signalling pathway in hepatocellular carcinoma

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 201-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with serum soluble inhibitors of Wnt‐β‐catenin signaling (sclerostin and dickkopf‐1) in patients undergoing peritoneal dialysis

By  

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 639-645

John Wiley & Sons Inc

Access to resources Recommend Favorite